T‐bet Regulates Ion Channels and Transporters and Induces Apoptosis in Intestinal Epithelial Cells
Advanced Science · 2024
DOI: 10.1002/advs.202401654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Lang Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX, 77030, USA. Hauptthemen laut MEDLINE: Apoptosis, T-Box Domain Proteins, Mice, Transgenic, Ion Channels. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, U.S. Department of Defense, National Cancer Institute.
Abstract (Originalsprache)
T‐bet, encoded by TBX21, is extensively expressed across various immune cell types, and orchestrates critical functions in their development, survival, and physiological activities. However, the role of T‐bet in non‐immune compartments, notably the epithelial cells, remains obscure. Herein, a Tet‐O‐T‐bet transgenic mouse strain is generated for doxycycline‐inducible T‐bet expression in adult animals. Unexpectedly, ubiquitous T‐bet overexpression causes acute diarrhea, intestinal damage, and rapid mortality. Cell‐type‐specific analyses reveal that T‐bet‐driven pathology is not attributable to its overexpression in CD4 + T cells or myeloid lineages. Instead, inducible T‐bet overexpression in the intestinal epithelial cells is the critical determinant of the observed lethal phenotype. Mechanistically, T‐bet overexpression modulates ion channel and transporter profiles in gut epithelial cells, triggering profound fluid secretion and subsequent lethal dehydration. Furthermore, ectopic T‐bet expression enhances gut epithelial cell apoptosis and markedly suppresses colon cancer development in xenograft models. Collectively, the findings unveil a previously unrecognized role of T‐bet in intestinal epithelial cells for inducing apoptosis, diarrhea, and local inflammation, thus implicating its potential as a therapeutic target for the treatment of cancer and inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX, 77030, USA.
- Department of General Surgery, Third Xiangya Hospital, Xiangya School of Medicine, Central South University, Changsha, 410013, China.
- Department of Pharmacology, School of Medicine, Southeast University, Nanjing, 210009, China.
- Department of Medicine, Baylor College of Medicine, Houston, TX, 77030, USA.
- Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA.
- Department of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, 410008, China.
ORCID-Profile: Rong-Fu Wang
Förderung
- NCI NIH HHS
- U.S. Department of Defense
- National Cancer Institute
Zitieren
APA
Chen, L., Yi, H., Li, Q., Duan, T., Liu, X., Li, L., Wang, H. Y., Xing, C., & Wang, R. F. (2024). T‐bet Regulates Ion Channels and Transporters and Induces Apoptosis in Intestinal Epithelial Cells. Advanced Science. https://doi.org/10.1002/advs.202401654
Vancouver
Chen L, Yi H, Li Q, Duan T, Liu X, Li L, et al. T‐bet Regulates Ion Channels and Transporters and Induces Apoptosis in Intestinal Epithelial Cells. Advanced Science. 2024. doi:10.1002/advs.202401654
BibTeX
@article{Chen2024,
author = {Chen, Lang and Yi, Hongwei and Li, Qingtian and Duan, Tianhao and Liu, Xin and Li, Linfeng and Wang, Helen Y and Xing, Changsheng and Wang, Rong-Fu},
title = {T‐bet Regulates Ion Channels and Transporters and Induces Apoptosis in Intestinal Epithelial Cells},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202401654}
}
EUVIMED